Education
About Us
Working with TipRanks
Follow Us
Hydration Pharmaceuticals Co. Ltd. (AU:HPC)
:HPC
RESEARCH TOOLSreports
HPC Stock Chart & Stats
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume65.65K
Average Volume (3M)742.55K
Market Cap
AU$6.03M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.20
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding430,800,930
10 Day Avg. Volume376,133
30 Day Avg. Volume742,555
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Hydration Pharmaceuticals Co. Ltd. News
HPC FAQ
What was Hydration Pharmaceuticals Co. Ltd.’s price range in the past 12 months?
Hydration Pharmaceuticals Co. Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Hydration Pharmaceuticals Co. Ltd.’s market cap?
Hydration Pharmaceuticals Co. Ltd.’s market cap is AU$6.03M.
When is Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date?
Hydration Pharmaceuticals Co. Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 28 days.
How were Hydration Pharmaceuticals Co. Ltd.’s earnings last quarter?
Hydration Pharmaceuticals Co. Ltd. released its earnings results on Feb 28, 2025. The company reported AU$0.014 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.014.
Is Hydration Pharmaceuticals Co. Ltd. overvalued?
According to Wall Street analysts Hydration Pharmaceuticals Co. Ltd.’s price is currently Overvalued.
Does Hydration Pharmaceuticals Co. Ltd. pay dividends?
Hydration Pharmaceuticals Co. Ltd. does not currently pay dividends.
What is Hydration Pharmaceuticals Co. Ltd.’s EPS estimate?
Hydration Pharmaceuticals Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hydration Pharmaceuticals Co. Ltd. have?
Hydration Pharmaceuticals Co. Ltd. has 430,800,930 shares outstanding.
What happened to Hydration Pharmaceuticals Co. Ltd.’s price movement after its last earnings report?
Hydration Pharmaceuticals Co. Ltd. reported an EPS of AU$0.014 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hydration Pharmaceuticals Co. Ltd.?
Currently, no hedge funds are holding shares in AU:HPC
Hydration Pharmaceuticals Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HPC Sentiment 70%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$128.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
―
20 days / 200 days
Momentum
40.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-4.38%
Trailing 12-Months
Company Description
Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited markets and sells a range of liquid, tablet, and powder healthy hydration products in Australia, the Unites States, and Canada. It sells its products under the Hydralyte brand name through retail stores and e-commerce channels. The company was founded in 2001 and is headquartered in San Diego, California.
Technical Analysis
Ownership Overview
34.72%
Insiders
―
Mutual Funds
― Other Institutional Investors
65.28% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---